FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Department of Medicine 5 – Haematology and Oncology
Friedrich-Alexander-Universität Erlangen-Nürnberg
Medizinische Fakultät
Einrichtungen, die zum Universitätsklinikum Erlangen gehören
Overview
Publications
(776)
Research Grants
(7)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee. (2024)
Greco R, Alexander T, Del Papa N, Müller F, Saccardi R, Sanchez-Guijo F, Schett G, et al.
Journal article, Review article
Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma. (2024)
Fuchs M, Jacob AS, Kaul H, Kobe C, Kuhnert G, Pabst T, Greil R, et al.
Journal article
BCL10 Deficiency Presenting as Severe Combined Immunodeficiency Escaping Newborn Screening (2024)
Salou S, Völkl S, Keller B, Ehl S, Naumann-Bartsch N
Journal article
Relevance of different prognostic scores in primary CNS lymphoma in the era of intensified treatment regimens: A retrospective, multicenter analysis of 174 patients (2024)
Zeremski V, Adolph L, Beer S, Berisha M, Jacobs B, Kahl C, Koenecke C, et al.
Journal article
Rescue therapy of antisynthetase syndrome with CD19-targeted CAR-T cells after failure of several B-cell depleting antibodies (2024)
Taubmann J, Knitza J, Müller F, Völkl S, Aigner M, Kleyer A, Gary R, et al.
Journal article, Letter
Cell type-specific modulation of metabolic, immune-regulatory, and anti-microbial pathways by CD101 (2024)
Wrage M, Holland T, Nüse B, Kaltwasser J, Fröhlich J, Arnold H, Gießler C, et al.
Journal article
Anti-angiogenic therapy in head and neck squamous cell carcinoma - current limitations and future directions (2024)
Nieberle F, Spoerl S, Głuszko A, Taxis J, Spanier G, Erber R, Spörl S, et al.
Journal article, Review article
Novel MAGIC composite scores using both clinical symptoms and biomarkers best predict treatment outcomes of acute GVHD (2024)
Akahoshi Y, Spyrou N, Weber D, Aguayo-Hiraldo P, Ayuk F, Chanswangphuwana C, Choe HK, et al.
Journal article
MoReLife – real-life data support the potential of momelotinib as a safe and effective treatment option for cytopenic myelofibrosis patients (2024)
Jilg S, Schwaab J, Sockel K, Crodel CC, Brückl V, Stegelmann F, Jentzsch M, et al.
Journal article
Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers. (2024)
Fischer-Riepe L, Kailayangiri S, Zimmermann K, Pfeifer R, Aigner M, Altvater B, Kretschmann S, et al.
Journal article
‹
1
...
3
4
5
6
7
...
77
›